F Bridge Bio Pharma, Inc. Transaction History
F
- $2.07 Billion
- Q1 2025
A detailed history of F transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, F holds 103,318 shares of BBIO stock, worth $5.08 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
103,318
Previous 97,198
6.3%
Holding current value
$5.08 Million
Previous $2.67 Million
33.9%
% of portfolio
0.17%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
376Shares Held
184MCall Options Held
12.8MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$1.09 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$948 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$733 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$613 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$353 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.3B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...